Gyre Therapeutics, Inc.
News
Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Globe Newswire SAN DIEGO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics ( Gyre ) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on a...\n more…
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Up 5.4% in August
Ticker Report Gyre Therapeutics, Inc. (NASDAQ:GYRE - Get Free Report) was the target of a significant growth in short interest during the month of August. As of August 15th, there was short interest totalling...\n more…
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up to $10.40
Ticker Report Gyre Therapeutics, Inc. (NASDAQ:GYRE - Get Free Report) shares gapped up before the market opened on Wednesday . The stock had previously closed at $10.40, but opened at $10.78. Gyre Therapeutics...\n more…
Gyre Therapeutics Second Quarter 2024 Earnings: EPS: US$0.041 (vs US$0.029 in 2Q 2023)
Simply Wall St Gyre Therapeutics ( NASDAQ:GYRE ) Second Quarter 2024 Results Key Financial Results Revenue: US$25.2m (down 14% from 2Q...\n more…
GYRE Stock Earnings: Gyre Therapeutics Reported Results for Q2 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nGyre Therapeutics just reported results for the second quarter of 2024.\nThe post GYRE Stock Earnings: Gyre Therapeutics Reported Results...\n more…